Thumb Osteoarthritis

Musculoskeletal

Prevalence

10000.0 / 100K

Incidence

600.0 / 100K/yr

6 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Ketorolac	Clearside Biomedical, Inc. (CLSDQ)
Triamcinolone	Valneva SE (VALN)

Phase 4(4)

Drug	Company
Botulinum Toxin A	Revance Therapeutics, Inc. (RVNC)
Ketorolac Injection	Valneva SE (VALN)
onabotulinumtoxin A	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 6 drugs in development for Thumb Osteoarthritis across 3 companies.

There are 1 clinical trial targeting Thumb Osteoarthritis tracked by BioSniper.

The estimated prevalence of Thumb Osteoarthritis is approximately 10000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.